<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015610"><a href="http://purl.obolibrary.org/obo/MONDO_0015610">MONDO:0015610</a></h3>
<p><strong>Label:</strong> rare acquired aplastic anemia</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0012197">MONDO:0012197</a> (aplastic anemia), <a href="http://purl.obolibrary.org/obo/MONDO_0010419">MONDO:0010419</a> (X-linked sideroblastic anemia), <a href="http://purl.obolibrary.org/obo/MONDO_0009692">MONDO:0009692</a> (primary myelofibrosis), <a href="http://purl.obolibrary.org/obo/MONDO_0015253">MONDO:0015253</a> (Diamond-Blackfan anemia), <a href="http://purl.obolibrary.org/obo/MONDO_0018641">MONDO:0018641</a> (paroxysmal nocturnal hemoglobinuria), <a href="http://purl.obolibrary.org/obo/MONDO_0008785">MONDO:0008785</a> (pyridoxine-refractory autosomal recessive sideroblastic anemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020113">MONDO:0020113</a> (red cell aplasia), <a href="http://purl.obolibrary.org/obo/MONDO_0016828">MONDO:0016828</a> (autosomal recessive sideroblastic anemia), <a href="http://purl.obolibrary.org/obo/MONDO_0019391">MONDO:0019391</a> (Fanconi anemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_88">Orphanet:88</a>, <a href="http://www.orpha.net/ORDO/Orphanet_124">Orphanet:124</a>, <a href="http://www.orpha.net/ORDO/Orphanet_255132">Orphanet:255132</a>, <a href="http://www.orpha.net/ORDO/Orphanet_84">Orphanet:84</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300751">OMIM:300751</a>, <a href="http://purl.obolibrary.org/obo/OMIM_182170">OMIM:182170</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254450">OMIM:254450</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615399">OMIM:615399</a>, <a href="http://purl.obolibrary.org/obo/OMIM_205950">OMIM:205950</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614742">OMIM:614742</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614743">OMIM:614743</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300818">OMIM:300818</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609135">OMIM:609135</a>, <a href="http://www.orpha.net/ORDO/Orphanet_824">Orphanet:824</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98421">Orphanet:98421</a>, <a href="http://www.orpha.net/ORDO/Orphanet_260305">Orphanet:260305</a>, <a href="http://www.orpha.net/ORDO/Orphanet_75563">Orphanet:75563</a>, <a href="http://www.orpha.net/ORDO/Orphanet_447">Orphanet:447</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 37.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system))) 37.20%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology))) 36.71%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology))) 36.71%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 36.19%</li>
<li>Thing 36.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 36.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 31.10%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001877">HP:0001877</a> (Abnormality of erythrocytes) 28.21%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) 24.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 24.28%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument) 23.24%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 22.49%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) 22.15%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002086">HP:0002086</a> (Abnormality of the respiratory system) 21.39%</li>
</ul>
</body>
</html>
